Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2026-04-28 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Allotment of ESOPs
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the exercise price, and the resulting change in the company's paid-up equity share capital. There is no financial report, earnings data, or management discussion. The document is an announcement related to share capital changes due to ESOP exercise and allotment. This fits the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication or certification, so it is not RPA or RNS. Therefore, the correct classification is SHA with high confidence.
2026-04-28 English
General Updates
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter from Viyash Scientific Limited addressed to stock exchanges, informing about the allotment of equity shares under the company's Employee Stock Option Plan 2020. It details the number of shares allotted, the exercise price, and the resulting change in the company's paid-up equity share capital. There are no financial statements, comprehensive financial data, or detailed analysis present. The document is an announcement of a capital change event (share allotment) rather than a full report or detailed financial disclosure. Given the content and context, this fits the category of Share Issue/Capital Change (SHA). The document length is short and focused solely on the share allotment event, confirming it is not a full report or regulatory filing of another type.
2026-04-28 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is an official communication from Viyash Scientific Limited to stock exchanges regarding a credit rating assigned by ICRA Limited to the company's long-term fund-based working capital facilities. It includes details of the rating, references to regulatory compliance under SEBI Listing Regulations, and the rating letter from ICRA. The content focuses on a credit rating update and related disclosures rather than financial results, management changes, or detailed financial reports. It is not an annual or interim report, earnings release, or management discussion. The document is a regulatory announcement about a credit rating update, which fits best under Capital/Financing Update (CAP) as it relates to the company's financing and credit facilities.
2026-04-22 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is an official communication from Viyash Scientific Limited to stock exchanges regarding a credit rating assigned by ICRA Limited to the company's long-term fund-based working capital facilities. It includes details of the rating, references to regulatory compliance under SEBI Listing Regulations, and the rating letter from ICRA. The content is focused on a credit rating update and financing-related information rather than a full financial report, earnings release, or management discussion. The document length is about 7,000 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial statements or management analysis. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it provides an update on the company's financing and credit rating status.
2026-04-22 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official announcement from Viyash Scientific Limited regarding the outcome of a Board Meeting held on April 22, 2026. It details the appointment of two additional directors, Mr. Amit Jain and Mr. Abhiroop Jayanthi, including their profiles and terms of appointment. It also mentions the approval of a revised ESOP pool. The document references compliance with SEBI Listing Regulations and includes annexures with detailed information about the directors. There are no financial statements, earnings data, or report publications. The content focuses on changes in the company's board of directors and related disclosures. Therefore, this document fits the category of Board/Management Information (MANG).
2026-04-22 English
Appointment of Directors
Board/Management Information Classification · 100% confidence The document is an official announcement from Viyash Scientific Limited regarding the outcome of a Board Meeting held on April 22, 2026. It details the appointment of two additional directors, Mr. Amit Jain and Mr. Abhiroop Jayanthi, including their profiles and terms of appointment. It also mentions the approval of a revised ESOP pool. The document references compliance with SEBI Listing Regulations and includes annexures with detailed information about the directors. There are no financial statements, earnings data, or report publications. The content focuses on changes in the company's board of directors and related governance matters. Therefore, this document fits the category of Board/Management Information (MANG).
2026-04-22 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.